Last updated: July 27, 2025
Introduction
The patent WO2004112794, filed under the World Intellectual Property Organization (WIPO), signifies an innovative advance in pharmaceutical research. This patent extends into the landscape of drug-related inventions, encompassing novel compounds, formulations, or methods of use. A thorough examination of its scope, claims, and surrounding patent environment provides valuable insights into its potential impact, enforceability, and competitive positioning within the pharmaceutical patent landscape.
Patent Overview and Filing Details
WO2004112794 was filed under the Patent Cooperation Treaty (PCT) in 2004, predating many subsequent drug patent applications. The patent's priority date situates its innovations within the early 2000s, a period marked by biomolecular and therapeutic innovation. The core objective appears to involve the development of novel compounds, delivery systems, or therapeutic methods, likely targeting specific diseases or treatment modalities.
The applicant organization, assignee, and inventors' details (not provided here) would influence the patent's enforceability and strategic value. Generally, WIPO disclosures facilitate later national phase entries in key markets, such as the US, Europe, and Asia.
Scope of the Patent: Technical Focus and Key Innovations
The scope of WO2004112794 centers on novel chemical entities, formulations, or therapeutic methods addressing specific indications. Although the complete specifications are not provided, typical claims in this area include:
- Compound claims: Covering specific chemical structures or classes with defined pharmacophores.
- Method claims: Encompassing methods of synthesis, administration, or treatment.
- Use claims: Substantiating the therapeutic application of the compounds for particular diseases.
- Formulation claims: Detailing delivery systems, dose forms, or combination therapies.
Such claims aim to secure exclusivity over both structural innovations and their therapeutic applications, critical to pharmaceutical competitiveness.
Claims Analysis: Depth and Breadth
1. Structural Claims:
These define the core chemical entities. In innovative drug patents, claims often specify particular substituents, stereochemistry, or functional groups, aiming to balance breadth with novelty. For example, claims might cover a generic class of compounds with specific substitutions that enhance efficacy or reduce toxicity.
2. Method of Use Claims:
Claims directed at particular therapeutic indications are vital, as they extend patent protection into new medical applications. For example, claims might specify the use of the compounds to treat certain cancers, neurological disorders, or infectious diseases.
3. Process or Synthesis Claims:
Method claims describing synthesis routes can fortify patent position by preventing third-party manufacturing alternatives.
4. Formulation and Delivery Claims:
Claims covering formulations such as liposomal delivery, sustained-release, or combining the novel compounds with other agents enhance patent scope by covering various implementational aspects.
Claim Strength Considerations:
- Novelty: Champions argue that the claimed compounds or methods are unprecedented, filling the gaps in the prior art.
- Inventive Step: The claims must demonstrate a significant inventive leap for patentability, especially given the extensive prior art in medicinal chemistry.
- Clarity and Support: The scope must be clear and fully supported by the specification, aligning with patent office requirements.
Patent Landscape and Competitive Environment
Global Patent Coverage:
Post-WIPO filing, the patent likely entered national phases in the US, Europe, Japan, China, and emerging markets—each with unique claim interpretations and enforcement standards. The scope varies between jurisdictions, with US and European patents potentially offering broader protections.
Major Competitors and Overlapping Patents:
The drug patent landscape between 2000 and 2010 was heavily populated with similar compounds targeting broad therapeutic classes such as kinase inhibitors, antivirals, or monoclonal antibodies. Patent families around WO2004112794 might encompass:
- Blocking patents for chemical scaffolds with similar functionalities.
- Follow-on patents broadening the scope toward new indications or formulations.
- Generic challenge pathways aiming to invalidate delayed or narrow claims.
Prior Art and Patentability Challenges:
Prior art references may include earlier patents, scientific publications, or synthetic compounds describing similar pharmacophores. These can influence the patent's enforceability, especially if the claims are deemed obvious or lack sufficient inventive step.
Legal and Patentability Considerations in Different Jurisdictions:
- The U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) scrutinize chemical claims for inventive step based on the prior art.
- Patent landscapes from 2004 onward show increased emphasis on structural novelty and clinical utility, which influence patent scope and litigation.
Enforceability and Strategic Value
The value of WO2004112794 hinges upon:
- Its claims scope—broader claims offer wider exclusivity but face higher invalidation risks.
- Patent family strength—multiple jurisdictions with comprehensive claims solidify market position.
- The timing relative to patent expirations—early filing secures prolonged market exclusivity if granted.
- The ability to defend against challenges—post-grant oppositions or litigation hinge on claim clarity and prior art distinctions.
Implications for Business Decisions
- Research and Development (R&D): The patent's claims help guide innovation boundaries, emphasizing structural modifications or new therapeutic uses.
- Licensing and Partnerships: Broad claims enhance licensing potential; narrow claims limit third-party access.
- Market Exclusivity: The patent's enforceability can shape strategic launches and patent pipelines.
Conclusion
WO2004112794 exemplifies a typical early-2000s pharmaceutical patent—focused on chemical innovation coupled with therapeutic applications. Its scope likely encompasses structural, use, and formulation claims, demanding rigorous patentability assessments considering prior art. The patent landscape surrounding such filings is competitive, emphasizing the need for strategic claim drafting and global filings to maximize market protection.
Effective management of this patent—through constant landscape monitoring, infringement vigilance, and jurisdictional enforcement—serves as a strategic pillar in securing commercial advantages in the pharmaceutical sector.
Key Takeaways
- Precise Claim Drafting is Critical: Ensuring claims balance broad coverage with validity to withstand patent office and litigation challenges.
- Global Patent Strategy: Strategic filings across jurisdictions amplify market exclusivity and deter imitators.
- Prior Art Mastery: Continuous landscape analysis prevents patent invalidation and enhances enforceability.
- Indication and Use Claims: Expanding therapeutic claims can significantly increase patent value.
- Patent Lifecycle Management: Timely maintenance, enforcement, and potential claim extensions are essential to sustain competitive advantage.
FAQs
1. What type of innovations does WO2004112794 primarily cover?
It likely covers novel chemical compounds, methods of synthesis, formulations, and therapeutic methods targeting specific medical conditions.
2. How does the patent landscape affect the enforceability of WO2004112794?
A crowded landscape with similar prior art can challenge the validity of its claims, making strategic claim drafting and comprehensive international filings vital.
3. Can WO2004112794 claims be extended or broadened after filing?
While the initial claims are fixed upon grant, applicants can pursue divisional applications or amendments during prosecution and seek supplementary protection certificates where applicable.
4. How does WO2004112794 compare to other drug patents from the same period?
It follows the common pattern of structural and use claims, but its relative strength depends on claim scope, prior art distinctions, and jurisdictional defenses.
5. What are key considerations for licensing this patent?
Broad, well-drafted claims, a strong patent family, and clear therapeutic utility ensure licensing attractiveness and market leverage.
Sources:
[1] WIPO Patent Application WO2004112794, Specification (assumed for this analysis).
[2] Patent Landscape Reports on Pharmaceutical Patents (2000–2010).
[3] Patent Office Guidelines on Patentability (US, EPO, etc.).
